Detalhe da pesquisa
1.
Cell-free DNA sequencing as a potential screening tool for phase I targeted treatment in refractory/relapse diffuse large B-cell lymphoma.
Haematologica
; 107(8): 1928-1932, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35320922
2.
Innovative therapies based on molecular orientation in patients with relapse and refractory diffuse large B-cell lymphoma: Results of LNH-EP1 study.
Am J Hematol
; 96(10): E376-E379, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34165816